Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2004 1
2005 3
2006 3
2007 2
2008 4
2009 6
2010 2
2011 5
2012 3
2013 5
2014 7
2015 7
2016 5
2017 6
2018 6
2019 5
2020 4
2021 15
2022 5
2023 10
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance.
Phillips DB, James MD, Vincent SG, Elbehairy AF, Neder JA, Kirby M, Ora J, Day AG, Tan WC, Bourbeau J, O'Donnell DE; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network. Phillips DB, et al. Am J Respir Crit Care Med. 2024 Jun 1;209(11):1314-1327. doi: 10.1164/rccm.202307-1184OC. Am J Respir Crit Care Med. 2024. PMID: 38170674
Nanoengineered silica: Properties, applications and toxicity.
Mebert AM, Baglole CJ, Desimone MF, Maysinger D. Mebert AM, et al. Among authors: baglole cj. Food Chem Toxicol. 2017 Nov;109(Pt 1):753-770. doi: 10.1016/j.fct.2017.05.054. Epub 2017 May 31. Food Chem Toxicol. 2017. PMID: 28578101 Review.
Alveolar macrophage function is impaired following inhalation of berry e-cigarette vapor.
Kulle A, Li Z, Kwak A, Mancini M, Young D, Avizonis DZ, Groleau M, Baglole CJ, Behr MA, King IL, Divangahi M, Langlais D, Wang J, Blagih J, Penz E, Dufour A, Thanabalasuriar A. Kulle A, et al. Among authors: baglole cj. Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2406294121. doi: 10.1073/pnas.2406294121. Epub 2024 Sep 23. Proc Natl Acad Sci U S A. 2024. PMID: 39312670 Free PMC article.
Editorial: Role of the Aryl Hydrocarbon Receptor in Immune Modulation.
Kaplan BLF, Baglole CJ, Sulentic CEW. Kaplan BLF, et al. Among authors: baglole cj. Front Toxicol. 2022 Jun 21;4:941665. doi: 10.3389/ftox.2022.941665. eCollection 2022. Front Toxicol. 2022. PMID: 35800177 Free PMC article. No abstract available.
Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study.
Krishnan S, Tan WC, Farias R, Aaron SD, Benedetti A, Chapman KR, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Walker B, Bourbeau J; Canadian Cohort Obstructive Lung Disease Collaborative Research Group and the Canadian Respiratory Research Network. Krishnan S, et al. Chest. 2023 Sep;164(3):637-649. doi: 10.1016/j.chest.2023.02.045. Epub 2023 Mar 4. Chest. 2023. PMID: 36871842
Opportunities and Challenges of Kava in Lung Cancer Prevention.
Freeman B, Mamallapalli J, Bian T, Ballas K, Lynch A, Scala A, Huo Z, Fredenburg KM, Bruijnzeel AW, Baglole CJ, Lu J, Salloum RG, Malaty J, Xing C. Freeman B, et al. Among authors: baglole cj. Int J Mol Sci. 2023 May 31;24(11):9539. doi: 10.3390/ijms24119539. Int J Mol Sci. 2023. PMID: 37298489 Free PMC article. Review.
Environmental immune disruptors, inflammation and cancer risk.
Thompson PA, Khatami M, Baglole CJ, Sun J, Harris SA, Moon EY, Al-Mulla F, Al-Temaimi R, Brown DG, Colacci A, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Lowe L, Guarnieri T, Bisson WH. Thompson PA, et al. Among authors: baglole cj. Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S232-53. doi: 10.1093/carcin/bgv038. Carcinogenesis. 2015. PMID: 26106141 Free PMC article. Review.
Biological Anti-IL-5/IL-5R Therapeutics for Chronic Obstructive Pulmonary Disease (COPD) with Specific Treatable Traits: A Real-World Retrospective Analysis.
Day de Larrañaga F, Joubert A, Drouin I, Ouellet I, Li PZ, Ross BA, Baglole CJ, Bourbeau J. Day de Larrañaga F, et al. Among authors: baglole cj. Int J Chron Obstruct Pulmon Dis. 2024 Jan 17;19:217-223. doi: 10.2147/COPD.S438153. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38249820 Free PMC article.
109 results